What’s best for diabetes after metformin? GRADE outdated at outsetJuly 2, 2021DiabetesCAD & AtherosclerosisStrokePreventive CareHeart FailureHypertensionLipid Disorders
EAS lipid guidance: Start high-risk patients on combo drugJune 29, 2021CAD & AtherosclerosisLipid DisordersAcute Coronary Syndromes
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetesJune 29, 2021DiabetesCAD & AtherosclerosisPreventive CareLipid Disorders
Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatmentJune 29, 2021DiabetesLipid DisordersPreventive CareCAD & Atherosclerosis
Maintain OMT for 5 years after revascularization, boost survival at 10 years: SYNTAXESJune 29, 2021CAD & AtherosclerosisInterventional Cardiology & SurgeryAcute Coronary SyndromesLipid Disorders
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight lossJune 27, 2021DiabetesLipid Disorders
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2DJune 26, 2021DiabetesLipid Disorders
Stopping statins linked to death, CV events in elderlyJune 25, 2021CAD & AtherosclerosisAcute Coronary SyndromesHypertensionLipid DisordersDiabetes
Clinicians slow to implement lipid-lowering guidelines: GOULD registryJune 23, 2021CAD & AtherosclerosisAcute Coronary SyndromesLipid DisordersPreventive Care
No overall statin effect seen on dementia, cognition in ASPREE analysisJune 23, 2021CAD & AtherosclerosisAcute Coronary SyndromesLipid DisordersDiabetes
Medically suspect criterion can determine bariatric surgery coverageJune 18, 2021HypertensionLipid DisordersBusiness of Medicine
Bariatric surgery cuts insulin needs in type 1 diabetes with severe obesityJune 17, 2021DiabetesLipid Disorders
Bariatric surgery’s cardiovascular benefit extends to 7 yearsJune 16, 2021Acute Coronary SyndromesCAD & AtherosclerosisHeart FailureLipid Disorders
